LEVERAGE LONG - NOVARTIS N Share Price

Certificat

89A1S

DE000SB50RJ5

Market Closed - Euronext Paris 17:30:01 26/04/2024 BST
3.013 EUR -9.14% Intraday chart for LEVERAGE LONG - NOVARTIS N
Current month+5.76%
1 month+21.89%
Date Price Change Volume
26/04/24 3.046 -8.14% 113
25/04/24 3.316 +9.69% 124
24/04/24 3.023 +4.57% 108
23/04/24 2.891 +22.14% 110
22/04/24 2.367 +17.41% 97

Real-time Euronext Paris

Last update April 26, 2024 at 05:30 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
89A1S
ISINDE000SB50RJ5
Date issued 06/10/2020
Maturity Unlimited
Parity 1 : 1
Emission price 46.55
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 51.92
Lowest since issue 1.467
Spread 0.388
Spread %12.12%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
97.84 USD
Average target price
108.5 USD
Spread / Average Target
+10.88%
Consensus
  1. Stock Market
  2. Certificates
  3. 89A1S Certificat